Source link : https://www.newshealth.biz/health-news/investigational-immunotherapy-combo-shows-promise-for-advanced-solid-tumors/
An investigational combination of CTLA-4 and PD‐1 checkpoint inhibitors demonstrated “encouraging” tumor activity, as well as a manageable safety profile, in patients with advanced/metastatic solid tumors, according to results from a small phase I study. Among 61 patients with different solid tumors who were evaluated for efficacy, 37.7% achieved an objective response to treatment with […]
Author : News Health
Publish date : 2024-02-26 16:23:28
Copyright for syndicated content belongs to the linked Source.